Sometimes, a delay is caused by a patent review, so the PTO will compensate a pharmaceutical company by extending the life of ...

Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of ...

The World Health Organization and partners on Friday set up a scheme to help bring mpox vaccines, tests and treatments to the ...

DelveInsight's Nontuberculous Mycobacterial Infection Market Insights report includes a comprehensive understanding of ...

GSK’s depemokimab, a new ultra-long-acting biologic, showed a 54% reduction in severe asthma exacerbations in the SWIFT-1 and ...

Flagship Pioneering has signed yet another strategic-level deal with a big pharma group, with GSK the latest to tap ... event back to the Royal Society of Medicine.

The revenue for GSK-3739937 is expected to reach an annual total of $7 ... which can be found on GlobalData’s Pharmaceutical Intelligence Center.

Glenmark Pharmaceuticals Ltd, Glaxosmithkline Pharmaceuticals Ltd, Biocon Ltd, Ajanta Pharma Ltd, Ipca Laboratories Ltd. Who is/are the promoter/promoters of Shukra Pharmaceuticals Ltd?

M K Hamied has resigned from his position as Vice Chairman and Non-Executive Director of the pharma company, effective October 29, due to age and health reasons. The Board has appointed Adil ...

Global healthcare company GlaxoSmithKline Pharmaceuticals Ltd on Tuesday (September 3) said it has received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order ...

The presentations highlight GSK’s commitment to advancing respiratory medicine, with a focus on achieving long ... and refractory chronic cough. The data aims to demonstrate how GSK’s innovative ...